SecBot SecBot
SECBOTREPLAY Home › Report › BDMD

BDMD · Nasdaq bid price deficiency

Baird Medical Investment Holdings Ltd · 6-K filed Nov 5, 2026 at 08:30 ET

At the news

BEARISHIMPACT 6/10

6-K filed Nov 5, 2026 at 08:30 ET

Baird Medical received a Nasdaq deficiency notice for its bid price being below $1.00 for 30 consecutive business days, triggering a 180-day compliance period through May 3, 2027. The company also issued a statement acknowledging recent share price volatility but citing no material undisclosed reason. With a market cap of only $5M, the delisting risk is material.

  • Nasdaq notified Baird Medical on November 2, 2026 that its bid price was below $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2).
  • The company has 180 calendar days, until May 3, 2027, to regain compliance by closing at $1.00 or above for 10 consecutive business days.
  • If compliance is not achieved by May 3, 2027, Baird Medical may be eligible for an additional 180-day grace period or face delisting.
  • The company issued a separate press release on November 4, 2026 stating it is not aware of any material development explaining the recent share price decline.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access